Improving ADHD Behavioral Care

Though the most effective treatment for children with Attention Deficit Hyperactivity
Disorder (ADHD) consists of combined medication and behavioral strategies, the vast majority
of children with ADHD are treated with medication only. One reason for the low rates of
behavioral treatment is that primary care pediatricians, not mental health professionals, are
responsible for treating the vast majority of children with ADHD. The investigators have
developed, tested, and are beginning to disseminate web-based software (mehealth for ADHD)
that has been shown in randomized clinical trials to improve the quality of ADHD medication
care delivered by pediatricians. The goal of the proposed study is to develop and test the
integration of behavioral tools into the evidence-based myadhdportal.com software in order to
improve access to behavioral treatment strategies, and ultimately improve outcomes for
children with ADHD. The automated algorithms and decision rules the investigators have
developed for creating and monitoring the behavioral tools ensure that behavioral treatments
like daily report cards and token economies are delivered in a manner that is consistent with
the evidence-base. The investigators are conducting a cluster randomized controlled trial in
community pediatric settings to test whether integration of the behavioral tools into the
myADHDportal.com software (1) increases rates of behavioral treatment; (2) facilitates better
integrity of behavioral interventions when implemented; (3) improves functional impairment in
children with ADHD; and (4) generates higher satisfaction with ADHD care. By continuing to
expand the functionality of the myADHDportal.com software, the investigators are increasing
patients' access to evidence-based care. This is especially critical for rural and
underserved communities who have no or limited access to evidence-based mental health
services. Moreover, by putting these behavioral tools in the hands of parents, teachers, and
pediatricians, the investigators are making it more likely that children will receive a high
quality of care that includes both medication management and behavioral strategies, thereby
improving the overall treatment outcomes of children with ADHD.